The latest Covaxin data may dent its appeal at a time when Bharat Biotech is ramping up production while studies show that most vaccines have reduced efficacy against the Delta variant.
Top Stories Nov 24, 2021, 5:40 PM IST
Covaxin, which uses traditional, inactivated-virus technology, "induces a robust antibody response" two weeks after two doses are given, The Lancet said in a statement.
Top Stories Nov 12, 2021, 10:31 AM IST
Ella was speaking at the Times Now Summit 2021, where he talked about the nasal vaccine being developed by Bharat Biotech after its Covaxin, he said that the Phase 2 trials are done and data was being analysed.
Top Stories Nov 11, 2021, 9:51 AM IST
This means that those inoculated with the Bharat Biotech-manufactured jab will not have to undergo self-isolation after arrival in England.
World News Nov 9, 2021, 12:24 PM IST
Bharat Biotech in a statement on Wednesday said that this approval is based on the availability of additional stability data, which was submitted to CDSCO.
Top Stories Nov 3, 2021, 5:52 PM IST
Covaxin has shown 77.8 percent efficacy against symptomatic Covid-19 and 65.2% protection against the novel Delta variant.
Top Stories Nov 3, 2021, 5:35 PM IST
In a statement, the Guyanese health ministry listed out the vaccines approved for the travellers who wish to visit the country.
India News Nov 2, 2021, 1:27 PM IST
Bharat Biotech has been submitting data to WHO on a rolling basis and submitted additional information at the UN health body's request on September 27.
Top Stories Oct 27, 2021, 9:16 AM IST
Millions of Indians have received the Bharat Biotech vaccine, yet many have been unable to travel due to the WHO's permission.
World News Oct 26, 2021, 7:00 PM IST
The officials confirmed that representatives from seven vaccine makers including Serum Institute of India, Bharat Biotech, Dr Reddy's Laboratories, Zydus Cadila, Biological E, Gennova Biopharma and Panacea Biotech will be participating in the meeting.
Top Stories Oct 23, 2021, 11:35 AM IST
Dr Ryan was replying to a query about if there would be a final response on Covaxin Emergency Use Listing by October 26 at a recent virtual Q&A.
World News Oct 22, 2021, 3:58 PM IST
Bharat Biotech has been submitting data to WHO on a rolling basis and WHO experts have reviewed these data.
Top Stories Oct 18, 2021, 7:34 PM IST
The recommendations have been forwarded to the Drugs Controller General of India (DCGI) for final approval.
Top Stories Oct 12, 2021, 5:50 PM IST
The Subject Expert Committee on Covid-19 approved emergency use approval to Bharat Biotech's Covaxin for children between 2-18 years.
Top Stories Oct 12, 2021, 1:26 PM IST
Spent over 30 years developing and testing the world's first malaria vaccine, Bharat Biotech is the global technology transfer recipient from GlaxoSmithKline (GSK).
Top Stories Oct 8, 2021, 9:37 AM IST